A new grant to University of Michigan Rogel Cancer Center member Arul Chinnaiyan, M.D., Ph.D., will provide long-term support to increase understanding of genetic markers of cancer to leverage targeted treatments.
The National Cancer Institute has awarded the University of Michigan Rogel Cancer Center a grant worth $33.4 million over five years. At the same time, the center’s designation as a “comprehensive cancer center” was renewed.
America’s opioid drug epidemic has struck hard in Michigan. But now, a team from the University of Michigan is striking back at a key factor: opioid prescriptions for patients before and after surgery.
As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
On October 13, 2016 a Centers for Disease Control (CDC) Health Advisory and Food & Drug Administration (FDA) Safety Communication announced that the Stöckert 3T heater/cooler devices by LivaNova PLC (formerly the Sorin Group) may have been contaminated with Mycobacterium chimaera (M.Chimaera), a rare type nontuberculous mycobacterium (NTM), during manufacturing.
The University of Michigan Comprehensive Cancer Center is one of 12 sites to joinPrecision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
U-M has established the Renal Pre-Competitive Consortium (RPC2), with several pharmaceutical companies, including AstraZeneca and Eli Lilly and Company. The consortium will develop and use large-scale data exploration to identify new treatment targets for chronic kidney disease.
It started out as a treatment for arthritis. But steered by science, it could become a first new approach in two decades for treating the damage that diabetes inflicts on the kidneys of millions of people.
Ann Arbor, Mich. – People given the gift of life – blood, organs, tissue or bone marrow – are grateful every day for the hero who gave them a second chance at life. In an inspirational new video, U-M patients share how their hero impacted them and their families with a life-saving donation.
Join us on World Kidney Day, 10 a.m.-3 p.m., March 15 for free kidney, blood pressure, and depression screenings. Throughout the day there'll be prize raffles, patient care information, exercise demonstrations, kidney-friendly cooking demonstrations and healthy snacks.
The Patient-Centered Outcomes Research Institute (PCORI) announced on June 20 that the University of Michigan has been selected to receive $650,000 to study and develop a patient centered decision support tool for management of nephrotic syndrome.
A study of adolescents with hypertension enrolled in the Michigan Medicaid program suggests that guideline-recommended diagnostic tests – echocardiograms and renal ultrasonography – were infrequently used, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.
After about a 4-year wait, years of dialysis treatments and 65 surgeries, Jai'Wan Davis-Harbour received a successful kidney transplant at C.S. Mott Children's Hospital. Because of a generous organ donor, Jai'Wan, 11, got a second chance at life.
On March 8, the University of Michigan Health System will host a World Kidney Day event that includes free kidney, blood pressure and depression screenings, plus prize raffles and information about kidney transplantation.
The National Institutes of Health is supporting a new effort to understand the complications of diabetes. The University of Michigan will look at the cellular changes that contribute to vision loss, kidney failure and nerve damage in type 1 diabetics.